A melanocortin receptor agonist studied for sexual dysfunction. FDA-approved as bremelanotide.
The journal of sexual medicine|2017|Croft H
BACKGROUND: The neurobiology of sexual response is driven in part by dopamine and serotonin-the former modulating excitatory pathways and the latter regulating inhibitory pathways. Neurobiological underpinnings of hypoactive sexual desire disorder (H…
Review
PMID: 29198512
The Journal of urology|2016|Seftel A
PMID: 27751477
Women's health (London, England)|2016|Clayton A et al.
AIM: Evaluate efficacy/safety of bremelanotide (BMT), a melanocortin-receptor-4 agonist, to treat female sexual dysfunctions in premenopausal women. METHODS: Patients randomized to receive placebo or BMT 0.75, 1.25 or 1.75 mg self-administered subcut…
Randomized Controlled Trial
PMID: 27181790
Expert opinion on investigational drugs|2015|Belkin Z, Krapf J, Goldstein A
INTRODUCTION: There is growing recognition of female sexual dysfunction (FSD) as an important women's health concern. Despite an increased awareness of the pathophysiologic components to FSD, currently, there are no drugs approved for the most common…
Review
PMID: 25376023
CNS drugs|2015|Kingsberg S, Clayton A, Pfaus J
How a woman responds to sexual cues is highly dependent on a number of distinct, yet related, factors. Researchers have attempted to explain the female sexual response for decades, but no single model reigns supreme. Proper female sexual function rel…
Review
PMID: 26519340
Expert opinion on investigational drugs|2014|Ückert S et al.
INTRODUCTION: Over the last 20 years, basic and clinical research activities studying the male and female sexual responses have led to several pharmacological options to treat male erectile dysfunction (ED) and female arousal and orgasmic disorders.…
Review
PMID: 25096243
Clinical toxicology (Philadelphia, Pa.)|2012|Nelson M, Bryant S, Aks S
INTRODUCTION: Melanotan products are currently purchased over the Internet and are designed to induce melanogenesis to create sunless tanning as well are used as sexual stimulants. We report a novel case of systemic toxicity with sympathomimetic exce…
Case Report
PMID: 23121206
The Urologic clinics of North America|2011|Kumar R, Nehra A
Several centrally acting agents have shown potential to improve erectile function in men with ED. They still lack adequate data in efficacy and tolerability. Nasal formulations of apomorphine and bremelanotide seem to be the most likely candidates fo…
Review
PMID: 21621083
British journal of pharmacology|2008|Aughton K et al.
BACKGROUND AND PURPOSE: Hypothalamic neuropeptides centrally modulate sexual arousal. However, the role of neuropeptides in peripheral arousal has been ignored. Vascular and non-vascular smooth muscle relaxation in the vagina is important for female…
Animal StudyIn Vitro
PMID: 18587425
Methods and findings in experimental and clinical pharmacology|2008|Tomillero A, Moral M
(+)-Dapoxetine hydrochloride, (R)-Etodolac; Abatacept, ABT-510, Adalimumab, Agatolimod sodium, Alemtuzumab, Alvocidib hydrochloride, Aminolevulinic acid methyl ester, Aripiprazole, AS01B, AS02B, AS02V, Azacitidine; Becatecarin, Bevacizumab, Bevirimat…
PMID: 18806898
Methods and findings in experimental and clinical pharmacology|2008|Tomillero A, Moral M
Gateways to clinical trials is a guide to the most recent trials in current literature and congresses. The data in the following tables has been retrieved from the Clinical Trials Knowledge Area of Prous Science Integrity(R), the drug discovery and d…
PMID: 19088949
The journal of sexual medicine|2008|Safarinejad M
This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article has been retracted at the request of the Editor-in-Chief. Following the retracti…
Randomized Controlled Trial
PMID: 18179455
The Journal of urology|2008|Safarinejad M, Hosseini S
PURPOSE: We evaluated the safety and efficacy of intranasal bremelanotide in men with erectile dysfunction who did not respond to sildenafil. MATERIALS AND METHODS: A total of 342 married men (28 to 59 years old) with erectile dysfunction who did not…
Randomized Controlled Trial
PMID: 18206919
International journal of impotence research|2008|Shadiack A, Althof S
The neurobiology of sexual behavior involves the interrelationships between sex steroids and neurotransmitters that result in both central nervous system (CNS) effects and effects in the genitalia. Tools such as positron emission tomography (PET) and…
Review
PMID: 18552829
International journal of impotence research|2008|Hellstrom W
Currently available agents for erectile dysfunction (ED) share the same mechanism of action and pharmacologic properties. Therefore, they share the same limitations, including a principal focus on erection as an end-organ process. One of the relative…
Review
PMID: 18552830
Current topics in medicinal chemistry|2007|King S et al.
Penile erection is a complex physiologic event resulting from the interactions of the nervous system on a highly specialized vascular organ. Activation of central nervous system melanocortinergic (MC) receptors with either endogenous or synthetic mel…
Animal Study
PMID: 17584130
The journal of sexual medicine|2007|Pfaus J, Giuliano F, Gelez H
INTRODUCTION: Bremelanotide is an analogue of the naturally occurring peptide alpha-melanocyte-stimulating hormone (alpha-MSH). It stimulates erection in men and male rats, and is currently in clinical trials for the treatment of erectile dysfunction…
Animal Study
PMID: 17958619
The journal of sexual medicine|2007|Perelman M
INTRODUCTION: Human sexual response involves a complex sequencing of interrelated mind/body processes. Few treatment options exist that address the complex multilayered etiological determinants of female sexual dysfunction (FSD). AIM: Review and eval…
Review
PMID: 17958620
Methods and findings in experimental and clinical pharmacology|2007|Bayes M, Rabasseda X, Prous J
(-)-Epigallocatechin gallate, [188Re]-P2045, 12B75, 89-12; Abacavir sulfate/lamivudine, Abatacept, Abiraterone acetate, ABT-869, Adalimumab, Ad-rh Endostatin, AI-700, Alemtuzumab, Alvimopan hydrate, Amrubicin hydrochloride, AP-12009, Apomab 7.3, Arfo…
PMID: 18040531
Current urology reports|2007|Carson C
Recent animal studies have resulted in newer central nervous system (CNS)-acting agents for the treatment of sexual dysfunction in men and women. CNS stimulation and control of sexual function primarily originates in the hypothalamus, medial preoptic…
Review
PMID: 18042327